Profile
Oliver CornelyOliver Cornely is Director & Chair Translational Research at the CECAD Institute of the University of Cologne, and Scientific Director of the Center for Clinical Trials. Clinically, he serves as Infectious Diseases Consultant at the Department of Internal Medicine, at the University Hospital of Cologne, Germany.
He is board certified in internal medicine, infectious diseases, haematology, oncology, and emergency medicine, and holds degrees in medical mycology and travel medicine.
Originating from an HIV/AIDS clinical research group, Dr Cornely’s research interest centres on infections in immunocompromised hosts, including invasive fungal diseases, antimicrobial resistance and Clostridium difficile infection.
Oliver Cornely is immediate-past President of the European Confederation of Medical Mycology (ECMM), the roof organization of 25 national mycology societies, and set up ECMM Guideline Program, ECMM Academy (Fellows program), and ECMM Excellence Center Initiative, designating clinical and microbiological excellence centres after an international audit procedure. He is currently on the Board of Directors of the US Mycoses Study Group Education & Research Consortium (MSGERC), is founder and chair of the Infectious Diseases Scientific Working Group of the European Hematology Association (EHA), and was recently elected as the Treasurer of the International Society for Human and Animal Mycology (ISHAM).
Oliver Cornely coordinates guidelines on invasive fungal infections and currently collaborates with mycologists from more than 50 countries on tailoring management guidelines to health care settings throughout the world.
He has published over 350 peer-reviewed articles, books, book chapters, and electronic media. He is a reviewer for numerous medical scientific journals, editorial board member for Haematologica, and Infectious Disease, and Editor-in-Chief of Mycoses.